Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 733-744 of 6190

Business Wire logo

CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 2025

ZINZINO AB (PUBL.): INTERIM REPORT FIRST QUARTER 2025

PR Newswire associated0

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation (IFLI) Announce The First Follicular Lymphoma (FL) Patient Treated with BAFF-R Targeting CAR-T Cells (PMB-CT01) Achieves a Complete Response

Race Walking Emerges as the Next Big Cardio Trend: Fast Walking for Optimal Fitness

PR Newswire associated0

Pintuition Validated as a Safe and Reliable Navigation Solution by Large Real-World Data from the iBRA-NET study

New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register

PR Newswire associated0

More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality

The acquisition of Reform RX marks iFIT’s expansion into the connected Pilates arena.

iFIT Inc. Enters Connected Pilates with Acquisition of Reform RX

PR Newswire associated0

BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025

Pulnovo Medical Welcomes EQT as a New Investor Following CE-MDR Approval, with Continued Support from Qiming Venture Partners

PR Newswire associated0

Lupin and Honeywell Move Forward Jointly with Plans for HFO Technology in Inhalers

PR Newswire associated0

Baxter launches HEMOPATCH Sealing Hemostat, a room-temperature collagen pad approved for Hemostasis and Sealing, suitable for open surgery and minimally invasive surgical procedures (MIS)

  • Prev Page
  • 1
  • 2
  • …
  • 61
  • 62
  • 63
  • …
  • 515
  • 516
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us